RIGL - Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion
2025-09-25 22:53:49 ET
Introduction
Rigel Pharmaceuticals (RIGL) is a commercial-stage biotechnology company that is developing oral small-molecule kinase inhibitors, which are used to help treat blood disorders and certain cancers. Despite having three commercialized products and margins significantly above peers, the market continues to value Rigel as if it were a single-asset, high-risk biotechnology company....
Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion